SOURCE: Carl Zeiss Meditec, Inc.
|
August 07, 2006 09:15 ET
Carl Zeiss Develops Camera Tailored to Ophthalmology
MediLive® Trio Eye™ From Carl Zeiss Is a 3-Chip Video Camera That Delivers Highly Detailed, High-Contrast, High-Resolution Video Images
DUBLIN, CA -- (MARKET WIRE) -- August 7, 2006 -- MediLive® Trio Eye™ was designed from the
ground up to fulfill the requirements of ophthalmic surgery. Users now
receive clear benefits compared to other cameras: During procedures on the
posterior segment of the eye with little light, they can still view bright,
high-contrast images on the monitor. If the camera is used for the anterior
segment, the video sequences provide details of the sclera without the
"blooming" effect from excessive brightness. As a result of these
advantages, the video images are ideal for presentations to colleagues or
students.
Preset configurations for the posterior and anterior segments of the eye
enable the MediLive® Trio Eye™ video camera to deliver brilliant
images quickly and easily. This is particularly beneficial when surgeons
switch between the two areas of application. Individual settings can be
saved and recalled anytime at the push of a button. The various camera
configurations for halogen illumination and Superlux Eye xenon illumination
can also be saved in this manner. White balance thus becomes unnecessary
when switching between the two types of illumination.
Combining the MediLive® Trio Eye™ camera with the OPMI® VISU 210
surgical microscope and Invertertube™ produces an ideal system for
retinal surgery.
Carl Zeiss is a globally leading international group of companies in the
optical and opto-electronic industry. Carl Zeiss AG is headquartered in
Oberkochen, Germany. The business groups, which each operate with sole
responsibility, are generally ranked first or second in the strategic
markets of biosciences and medical technology, system solutions for
industry and optical consumer goods. They offer products and services for
biomedical research and medical technology, system solutions for the
semiconductor, automotive and mechanical engineering industries, as well as
high-quality consumer goods such as camera lenses and binoculars. In fiscal
year 2004/05 (ended 30 September) the Carl Zeiss Group generated sales
totaling EUR 2,222 million.
Carl Zeiss has approximately 11,500 employees, including about 3,300
outside Germany. The Carl Zeiss Group is directly represented in more than
30 countries and operates production facilities in Europe, America and
Asia.
The eyeglass business now operates as Carl Zeiss Vision International GmbH
and is the number two eyeglass provider in the world. This company is owned
50:50 by Carl Zeiss AG and a private equity company. Further information is
available at www.zeiss.de/presse.
Carl Zeiss Surgical
5161 Hacienda Drive
Dublin, CA 94568